Category: Chronic Pulmonary Disorders

Chronic Pulmonary Disorders

Protein Discovery Paves Way for Blood Test to Diagnose Asthma

Scientists at Rutgers Health have discovered that a simple blood test could diagnose asthma and determine its severity.

Chronic Pulmonary Disorders

‘Undeniable Link’ Between Primary Ciliary Dyskinesia and Asthma in Kids

Children with primary ciliary dyskinesia, a rare genetic disorder affecting airway function, are 22 times more likely to have asthma than children without PCD, research shows.

Chronic Pulmonary Disorders

Common Chemicals in Lotions and Cleaners Linked to Asthma Risk in Kids

Maternal exposure to certain chemicals found in everyday products during pregnancy could increase a child's risk of developing asthma.

Asthma

DLCO and Asthma Management

Diffusion capacity of the lungs for carbon monoxide (DLCO) testing is used to assess the transfer of gases from the alveoli into the bloodstream. Abnormal DLCO results can help diagnose, distinguish, and manage cardiopulmonary diseases such as asthma.

COPD

2025 GOLD Report on COPD

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has posted a draft of its annual 2025 GOLD Report on COPD diagnosis, management, and prevention.

Cystic fibrosis

FDA Awards Rare Pediatric Disease Designation to Investigational Cystic Fibrosis Treatment

ETD001 aims to improve lung function by targeting mucus clearance in patients with high unmet medical needs.

Pulmonary Fibrosis

Pulmonary Fibrosis Foundation Launches Educational Resource for Newly Diagnosed Patients

The online resource aims to offer patients with pulmonary fibrosis and interstitial lung disease guidance and support in the early months after diagnosis.

Allergies

Air Purifier Reduces Symptoms and Improves Sleep for People with Allergies, Study Finds

The air purifier improved deep sleep and reduced allergy symptoms in adults with nighttime allergies, based on objective sleep measurements and participant feedback.

Other Chronic Diseases

Investigational Brensocatib Reduces Exacerbations Across Most Bronchiectasis Subgroups

New sub-analyses show that brensocatib reduced pulmonary exacerbations and slowed lung function decline for most subgroups of patients with non-cystic fibrosis bronchiectasis.